GENESIS Pharma
Stelios Moschonas has extensive experience in the pharmaceutical industry, currently serving as a Product Manager for Oncology and Haematology at Genesis Pharma since January 2006, following a role as a Product Specialist in Haematology. Prior to this, Stelios held the position of Sales Representative at Pfizer from January 1998 to February 2006. Stelios holds a Master of Business Administration (M.B.A.) from the Hellenic School of Business Administration (2014-2016) and a Bachelor of Science in Physiotherapy from the Technological Educational Institute of Athens (1992-1996).
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com